Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 14, 2024Diabetes

914-P: Association of Sodium–Glucose Cotransporter 2 Inhibitors with Risk of Diabetic Ketoacidosis among Hospitalized Patients—A Multicentre Cohort Study

View Full Paper
Ask AI
Bookmark
Share

Authors

SSShohinee SarmaBHBenazir Hodzic-SantorMCMICHAEL COLACCI

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sarma et al. (2024) studied this question.

synapsesocial.com/papers/68e64c4bb6db6435875dcfd7https://doi.org/10.2337/db24-914-p
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Sodium–Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis2020 · 184 citations
  2. 2Clinical Severity of Diabetic Ketoacidosis by SGLT2 Inhibitors Use: A Retrospective Observational Study2026
  3. 3Risk of Diabetic Ketoacidosis Associated with Sodium Glucose Cotransporter-2 Inhibitors: A Network Meta-Analysis and Meta-Regression2024 · 23 citations
  4. 4Risk of diabetic ketoacidosis with sodium-glucose cotransporter-2 inhibitors compared with dipeptidyl peptidase-4 inhibitors in type 2 diabetes: A nationwide cohort study2026
  5. 5Association of sodium glucose co-transporter-2 inhibitors with risk of diabetic ketoacidosis among hospitalized patients: A multicentre cohort study2024 · 8 citations